Tyra Biosciences Inc (NASDAQ: TYRA) on Tuesday, plunged -4.76% from the previous trading day, before settling in for the closing price of $10.50. Within the past 52 weeks, TYRA’s price has moved between $6.42 and $29.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -42.36%. With a float of $30.76 million, this company’s outstanding shares have now reached $50.75 million.
In an organization with 60 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tyra Biosciences Inc (TYRA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tyra Biosciences Inc is 39.40%, while institutional ownership is 62.76%. The most recent insider transaction that took place on Feb 05 ’25, was worth 74,324. In this transaction Director of this company sold 5,401 shares at a rate of $13.76, taking the stock ownership to the 443,885 shares. Before that another transaction happened on Feb 05 ’25, when Company’s Director proposed sale 120,000 for $13.75, making the entire transaction worth $1,650,000.
Tyra Biosciences Inc (TYRA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -42.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -19.24% during the next five years compared to -73.69% drop over the previous five years of trading.
Tyra Biosciences Inc (NASDAQ: TYRA) Trading Performance Indicators
Tyra Biosciences Inc (TYRA) is currently performing well based on its current performance indicators. A quick ratio of 23.81 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -2.34 in one year’s time.
Technical Analysis of Tyra Biosciences Inc (TYRA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.36 million. That was better than the volume of 0.31 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.09%. Additionally, its Average True Range was 0.72.
During the past 100 days, Tyra Biosciences Inc’s (TYRA) raw stochastic average was set at 33.00%, which indicates a significant decrease from 68.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.54% in the past 14 days, which was lower than the 58.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.97, while its 200-day Moving Average is $16.33. However, in the short run, Tyra Biosciences Inc’s stock first resistance to watch stands at $10.35. Second resistance stands at $10.71. The third major resistance level sits at $11.05. If the price goes on to break the first support level at $9.65, it is likely to go to the next support level at $9.31. Assuming the price breaks the second support level, the third support level stands at $8.95.
Tyra Biosciences Inc (NASDAQ: TYRA) Key Stats
Market capitalization of the company is 530.90 million based on 53,090K outstanding shares. Right now, sales total 0 K and income totals -86,480 K. The company made 0 K in profit during its latest quarter, and -25,570 K in sales during its previous quarter.
